For example, mutations in the chromatin modifying genes CREBBP, KMT2D and EZH2, were described as characteristic of GCB-type DLBCL and chromosome 18q gain and MYD88 mutations characteristic of ABC-type DLBCL. This evidence concerns the gene KMT2D and diffuse large B-cell lymphoma.